Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 16 | 2024 | 218 | 4.200 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 39 | 2024 | 286 | 3.870 |
Why?
|
Vasculitis | 14 | 2013 | 521 | 1.770 |
Why?
|
Glomerulonephritis, Membranous | 5 | 2021 | 86 | 1.630 |
Why?
|
Autoantibodies | 18 | 2017 | 2036 | 1.390 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 4 | 2014 | 694 | 1.340 |
Why?
|
Peroxidase | 16 | 2017 | 610 | 1.340 |
Why?
|
Immunologic Factors | 5 | 2021 | 1575 | 1.260 |
Why?
|
Myeloblastin | 15 | 2017 | 99 | 1.020 |
Why?
|
Autoimmune Diseases | 5 | 2021 | 2130 | 0.820 |
Why?
|
Immunosuppressive Agents | 9 | 2024 | 4147 | 0.800 |
Why?
|
Hemofiltration | 4 | 2006 | 57 | 0.750 |
Why?
|
Glomerulonephritis | 9 | 2018 | 372 | 0.710 |
Why?
|
Paranasal Sinuses | 2 | 2021 | 249 | 0.690 |
Why?
|
Cyclophosphamide | 5 | 2021 | 2236 | 0.680 |
Why?
|
Prednisone | 3 | 2021 | 1567 | 0.670 |
Why?
|
Levamisole | 3 | 2014 | 35 | 0.660 |
Why?
|
Nose | 1 | 2021 | 509 | 0.600 |
Why?
|
Neutropenia | 2 | 2020 | 891 | 0.590 |
Why?
|
Serine Endopeptidases | 13 | 2003 | 1073 | 0.520 |
Why?
|
Fever | 2 | 2020 | 1612 | 0.480 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2014 | 65 | 0.480 |
Why?
|
Drug Contamination | 2 | 2014 | 148 | 0.480 |
Why?
|
Glucocorticoids | 2 | 2020 | 2107 | 0.450 |
Why?
|
Citric Acid | 2 | 2006 | 126 | 0.430 |
Why?
|
Remission Induction | 5 | 2024 | 2384 | 0.430 |
Why?
|
Immunoglobulin G | 7 | 2019 | 4554 | 0.420 |
Why?
|
Cannabinoids | 1 | 2014 | 166 | 0.410 |
Why?
|
Cocaine | 2 | 2014 | 1008 | 0.410 |
Why?
|
Cocaine-Related Disorders | 2 | 2014 | 460 | 0.400 |
Why?
|
Antibodies, Viral | 2 | 2023 | 3164 | 0.380 |
Why?
|
Receptors, Phospholipase A2 | 2 | 2021 | 33 | 0.370 |
Why?
|
B-Lymphocytes | 4 | 2021 | 4664 | 0.360 |
Why?
|
Propylthiouracil | 3 | 2014 | 69 | 0.340 |
Why?
|
Recurrence | 6 | 2024 | 8333 | 0.330 |
Why?
|
Glomerulosclerosis, Focal Segmental | 2 | 2021 | 359 | 0.300 |
Why?
|
Antirheumatic Agents | 1 | 2017 | 1335 | 0.300 |
Why?
|
Kidney Glomerulus | 6 | 1997 | 697 | 0.290 |
Why?
|
Androgens | 1 | 2014 | 1271 | 0.290 |
Why?
|
Sepsis | 1 | 2020 | 2589 | 0.280 |
Why?
|
Adjuvants, Immunologic | 1 | 2011 | 1000 | 0.280 |
Why?
|
Anticoagulants | 4 | 2006 | 4595 | 0.260 |
Why?
|
Autoantigens | 8 | 2003 | 891 | 0.250 |
Why?
|
Lactates | 1 | 2006 | 432 | 0.250 |
Why?
|
Basement Membrane | 3 | 2002 | 356 | 0.240 |
Why?
|
Drug Therapy, Combination | 4 | 2020 | 6483 | 0.230 |
Why?
|
Scleritis | 3 | 2020 | 100 | 0.220 |
Why?
|
Kidney Diseases | 1 | 2014 | 2145 | 0.220 |
Why?
|
Pregnancy Outcome | 1 | 2013 | 2795 | 0.220 |
Why?
|
Antibody Specificity | 5 | 2013 | 1094 | 0.210 |
Why?
|
Hemoptysis | 2 | 2002 | 155 | 0.200 |
Why?
|
Plasmapheresis | 2 | 2020 | 212 | 0.200 |
Why?
|
Vaginitis | 1 | 2021 | 46 | 0.200 |
Why?
|
Vaginal Discharge | 1 | 2021 | 25 | 0.200 |
Why?
|
Microscopic Polyangiitis | 1 | 2021 | 45 | 0.200 |
Why?
|
Citrates | 2 | 1999 | 131 | 0.190 |
Why?
|
Filgrastim | 1 | 2020 | 132 | 0.190 |
Why?
|
Allopurinol | 2 | 2000 | 185 | 0.190 |
Why?
|
Nephrosis, Lipoid | 1 | 2020 | 51 | 0.190 |
Why?
|
Hematologic Agents | 1 | 2020 | 39 | 0.190 |
Why?
|
Humans | 78 | 2024 | 742088 | 0.190 |
Why?
|
Retrospective Studies | 13 | 2021 | 77098 | 0.180 |
Why?
|
Kidney Failure, Chronic | 3 | 2018 | 2536 | 0.180 |
Why?
|
Azathioprine | 1 | 2020 | 355 | 0.170 |
Why?
|
Plasma Exchange | 1 | 2020 | 155 | 0.170 |
Why?
|
Drug Administration Schedule | 4 | 2021 | 4929 | 0.170 |
Why?
|
Hydralazine | 2 | 2014 | 38 | 0.170 |
Why?
|
Vasculitis, Leukocytoclastic, Cutaneous | 1 | 1999 | 41 | 0.170 |
Why?
|
Opportunistic Infections | 1 | 2002 | 389 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20086 | 0.170 |
Why?
|
Mycophenolic Acid | 1 | 2020 | 343 | 0.160 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 552 | 0.150 |
Why?
|
Skin | 2 | 2020 | 4353 | 0.150 |
Why?
|
Adult | 25 | 2021 | 213712 | 0.150 |
Why?
|
Minocycline | 2 | 2014 | 163 | 0.150 |
Why?
|
Middle Aged | 33 | 2021 | 213127 | 0.150 |
Why?
|
Gout Suppressants | 1 | 1998 | 160 | 0.150 |
Why?
|
Hemorrhage | 3 | 1999 | 3461 | 0.140 |
Why?
|
Treatment Outcome | 9 | 2024 | 62966 | 0.140 |
Why?
|
Female | 38 | 2021 | 379592 | 0.140 |
Why?
|
Spinal Cord Diseases | 1 | 1998 | 299 | 0.130 |
Why?
|
Laryngostenosis | 1 | 2017 | 161 | 0.130 |
Why?
|
Laryngectomy | 1 | 2017 | 248 | 0.130 |
Why?
|
Kidney Transplantation | 3 | 2021 | 4246 | 0.130 |
Why?
|
Male | 35 | 2021 | 349538 | 0.130 |
Why?
|
Nephritis | 1 | 1996 | 158 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 8 | 2003 | 3862 | 0.130 |
Why?
|
Myelinolysis, Central Pontine | 1 | 2014 | 18 | 0.120 |
Why?
|
Fluorescent Antibody Technique, Indirect | 5 | 2003 | 428 | 0.120 |
Why?
|
Connective Tissue Diseases | 1 | 1997 | 264 | 0.120 |
Why?
|
Muscular Diseases | 1 | 1998 | 557 | 0.120 |
Why?
|
Methotrexate | 1 | 2020 | 1720 | 0.120 |
Why?
|
Aged | 21 | 2021 | 162944 | 0.120 |
Why?
|
Tracheostomy | 1 | 2017 | 400 | 0.120 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2017 | 546 | 0.110 |
Why?
|
Diplopia | 1 | 2014 | 199 | 0.110 |
Why?
|
Lung Diseases | 3 | 2003 | 1884 | 0.110 |
Why?
|
Maternal-Fetal Exchange | 2 | 2013 | 455 | 0.110 |
Why?
|
Churg-Strauss Syndrome | 3 | 2001 | 70 | 0.100 |
Why?
|
Sinusitis | 1 | 2021 | 922 | 0.100 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 1 | 2011 | 52 | 0.100 |
Why?
|
Anabolic Agents | 1 | 2014 | 247 | 0.100 |
Why?
|
Radioimmunoassay | 2 | 1992 | 918 | 0.100 |
Why?
|
Drug Combinations | 1 | 2017 | 1961 | 0.100 |
Why?
|
Renal Replacement Therapy | 1 | 2013 | 258 | 0.100 |
Why?
|
Hematuria | 3 | 2020 | 235 | 0.090 |
Why?
|
Penicillamine | 2 | 2000 | 59 | 0.090 |
Why?
|
Sulfasalazine | 2 | 2000 | 79 | 0.090 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2011 | 349 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 2 | 2017 | 1788 | 0.090 |
Why?
|
Administration, Oral | 2 | 2017 | 3913 | 0.090 |
Why?
|
Infusions, Intravenous | 1 | 2014 | 2271 | 0.080 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2020 | 2099 | 0.080 |
Why?
|
Incidence | 3 | 2021 | 20928 | 0.080 |
Why?
|
Escherichia coli Infections | 1 | 2011 | 532 | 0.080 |
Why?
|
Predictive Value of Tests | 8 | 2003 | 15056 | 0.080 |
Why?
|
Prospective Studies | 7 | 2024 | 53187 | 0.070 |
Why?
|
Diagnosis, Differential | 7 | 2020 | 12958 | 0.070 |
Why?
|
Exanthema | 2 | 2020 | 488 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39004 | 0.070 |
Why?
|
Epitopes | 1 | 2013 | 2569 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12344 | 0.070 |
Why?
|
Arteritis | 2 | 2002 | 159 | 0.070 |
Why?
|
Creatinine | 1 | 2011 | 1916 | 0.070 |
Why?
|
Isotonic Solutions | 1 | 2006 | 119 | 0.070 |
Why?
|
Thrombosis | 1 | 1999 | 2966 | 0.070 |
Why?
|
Time Factors | 4 | 2021 | 40054 | 0.070 |
Why?
|
Urinary Tract Infections | 1 | 2011 | 786 | 0.070 |
Why?
|
Solutions | 1 | 2006 | 426 | 0.060 |
Why?
|
Immunity, Cellular | 1 | 2011 | 1606 | 0.060 |
Why?
|
Bicarbonates | 1 | 2006 | 313 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.060 |
Why?
|
Secondary Prevention | 2 | 2018 | 1520 | 0.060 |
Why?
|
Anti-Glomerular Basement Membrane Disease | 2 | 2002 | 42 | 0.060 |
Why?
|
Nipecotic Acids | 1 | 2023 | 38 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6534 | 0.060 |
Why?
|
Blood Sedimentation | 2 | 2020 | 231 | 0.050 |
Why?
|
Lupus Vasculitis, Central Nervous System | 1 | 2002 | 33 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2017 | 13921 | 0.050 |
Why?
|
Neutrophils | 3 | 1997 | 3711 | 0.050 |
Why?
|
Aged, 80 and over | 7 | 2013 | 57683 | 0.050 |
Why?
|
Cryoglobulinemia | 1 | 2002 | 87 | 0.050 |
Why?
|
Membrane Glycoproteins | 5 | 1994 | 3769 | 0.050 |
Why?
|
Antibodies | 3 | 2000 | 2459 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2013 | 2407 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 5 | 1992 | 2505 | 0.050 |
Why?
|
Acute Kidney Injury | 1 | 2013 | 1967 | 0.050 |
Why?
|
Multiple Organ Failure | 1 | 2003 | 389 | 0.050 |
Why?
|
Endocarditis, Subacute Bacterial | 1 | 2000 | 8 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11690 | 0.050 |
Why?
|
Risk Factors | 3 | 2021 | 72145 | 0.050 |
Why?
|
Survival Rate | 1 | 2014 | 12773 | 0.040 |
Why?
|
Syndrome | 2 | 1996 | 3248 | 0.040 |
Why?
|
Risk Assessment | 3 | 2021 | 23320 | 0.040 |
Why?
|
Antithyroid Agents | 1 | 1999 | 68 | 0.040 |
Why?
|
Epoprostenol | 1 | 1999 | 254 | 0.040 |
Why?
|
Aniline Compounds | 1 | 2023 | 983 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2010 | 15530 | 0.040 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1998 | 147 | 0.040 |
Why?
|
Kidney Tubules, Proximal | 2 | 1991 | 417 | 0.040 |
Why?
|
Hypergammaglobulinemia | 1 | 1997 | 74 | 0.040 |
Why?
|
Sensitivity and Specificity | 5 | 2011 | 14720 | 0.040 |
Why?
|
Cytoplasm | 3 | 1993 | 1539 | 0.040 |
Why?
|
Paresthesia | 1 | 1998 | 162 | 0.040 |
Why?
|
Glomerulonephritis, IGA | 1 | 1998 | 66 | 0.040 |
Why?
|
Immunoglobulin A | 2 | 1998 | 992 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 1997 | 804 | 0.040 |
Why?
|
Boston | 1 | 2010 | 9305 | 0.040 |
Why?
|
beta 2-Microglobulin | 1 | 1997 | 315 | 0.040 |
Why?
|
Lipid Bilayers | 1 | 1999 | 381 | 0.040 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 1998 | 131 | 0.040 |
Why?
|
Interleukins | 1 | 2001 | 791 | 0.030 |
Why?
|
Arthralgia | 1 | 2020 | 456 | 0.030 |
Why?
|
Heymann Nephritis Antigenic Complex | 5 | 1994 | 16 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 1999 | 545 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 1998 | 1799 | 0.030 |
Why?
|
Prognosis | 3 | 2018 | 29010 | 0.030 |
Why?
|
Leg | 1 | 2020 | 1110 | 0.030 |
Why?
|
Eye Diseases | 1 | 2020 | 670 | 0.030 |
Why?
|
Young Adult | 3 | 2021 | 56350 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 9941 | 0.030 |
Why?
|
Immunoglobulins | 1 | 1997 | 880 | 0.030 |
Why?
|
Registries | 2 | 2021 | 8077 | 0.030 |
Why?
|
Waiting Lists | 1 | 2018 | 692 | 0.030 |
Why?
|
Amino Acid Sequence | 5 | 2013 | 13814 | 0.030 |
Why?
|
Adolescent | 5 | 2013 | 85649 | 0.030 |
Why?
|
Polyarteritis Nodosa | 1 | 1994 | 66 | 0.030 |
Why?
|
Fatal Outcome | 2 | 2014 | 1849 | 0.030 |
Why?
|
Hematologic Tests | 1 | 2014 | 238 | 0.030 |
Why?
|
Ceruloplasmin | 1 | 2013 | 56 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2013 | 25575 | 0.030 |
Why?
|
Molecular Sequence Data | 5 | 2013 | 18112 | 0.030 |
Why?
|
Pregnancy | 2 | 2013 | 29087 | 0.030 |
Why?
|
Pulmonary Alveoli | 2 | 1993 | 675 | 0.030 |
Why?
|
Heparin | 1 | 1999 | 1636 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2003 | 6891 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4438 | 0.030 |
Why?
|
Immunoassay | 1 | 1996 | 752 | 0.030 |
Why?
|
Rats, Inbred WKY | 1 | 2011 | 158 | 0.030 |
Why?
|
C-Reactive Protein | 2 | 2020 | 3766 | 0.030 |
Why?
|
Vaccination | 1 | 2023 | 3256 | 0.020 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1991 | 225 | 0.020 |
Why?
|
Sjogren's Syndrome | 1 | 1992 | 229 | 0.020 |
Why?
|
Survival Analysis | 2 | 2001 | 10248 | 0.020 |
Why?
|
Colitis | 1 | 1997 | 1149 | 0.020 |
Why?
|
Kidney Cortex | 1 | 1989 | 186 | 0.020 |
Why?
|
Kidney | 3 | 2011 | 7167 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1991 | 1676 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2002 | 3679 | 0.020 |
Why?
|
Glycoproteins | 2 | 1994 | 2260 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2001 | 1901 | 0.020 |
Why?
|
Pancreas Transplantation | 1 | 1989 | 188 | 0.020 |
Why?
|
Rats | 7 | 2011 | 24265 | 0.020 |
Why?
|
United States | 3 | 2021 | 69693 | 0.020 |
Why?
|
Colchicine | 1 | 1989 | 242 | 0.020 |
Why?
|
Brain | 1 | 2014 | 26343 | 0.020 |
Why?
|
Molecular Weight | 1 | 1989 | 2255 | 0.020 |
Why?
|
Biopsy | 2 | 1996 | 6756 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1999 | 3067 | 0.020 |
Why?
|
Receptors, LDL | 1 | 1989 | 475 | 0.020 |
Why?
|
Blotting, Western | 2 | 1997 | 5180 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 1992 | 1640 | 0.020 |
Why?
|
Endocytosis | 1 | 1991 | 983 | 0.020 |
Why?
|
Hyponatremia | 1 | 1989 | 298 | 0.020 |
Why?
|
Rats, Inbred Lew | 3 | 1993 | 1161 | 0.020 |
Why?
|
Antigens | 1 | 1991 | 1462 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40450 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 1994 | 2867 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8297 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2013 | 21719 | 0.020 |
Why?
|
LDL-Receptor Related Protein-Associated Protein | 2 | 1994 | 17 | 0.020 |
Why?
|
Lung | 1 | 2002 | 9826 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10372 | 0.010 |
Why?
|
Medicare | 1 | 2021 | 6532 | 0.010 |
Why?
|
Carrier Proteins | 2 | 1994 | 5019 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2011 | 4200 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 35342 | 0.010 |
Why?
|
Child | 3 | 2013 | 77478 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 1993 | 11363 | 0.010 |
Why?
|
Animals | 11 | 2013 | 168561 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13256 | 0.010 |
Why?
|
Seroepidemiologic Studies | 1 | 2003 | 402 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2003 | 981 | 0.010 |
Why?
|
Antigen-Antibody Complex | 2 | 1993 | 517 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9735 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2013 | 5095 | 0.010 |
Why?
|
Interleukin-15 | 1 | 2001 | 184 | 0.010 |
Why?
|
Antibodies, Monoclonal | 3 | 1997 | 9274 | 0.010 |
Why?
|
Affinity Labels | 1 | 1999 | 109 | 0.010 |
Why?
|
Calorimetry, Differential Scanning | 1 | 1999 | 94 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2013 | 5310 | 0.010 |
Why?
|
Spectrophotometry | 1 | 1999 | 313 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1990 | 1086 | 0.010 |
Why?
|
Disease Models, Animal | 3 | 2011 | 18006 | 0.010 |
Why?
|
Leukocyte Elastase | 1 | 1999 | 113 | 0.010 |
Why?
|
Antigens, T-Independent | 1 | 1997 | 21 | 0.010 |
Why?
|
Mice, Inbred NZB | 1 | 1997 | 56 | 0.010 |
Why?
|
IgG Deficiency | 1 | 1997 | 28 | 0.010 |
Why?
|
Ficoll | 1 | 1997 | 40 | 0.010 |
Why?
|
Proteins | 1 | 1993 | 6096 | 0.010 |
Why?
|
Mice, Inbred MRL lpr | 1 | 1997 | 159 | 0.010 |
Why?
|
Cell Extracts | 1 | 1997 | 138 | 0.010 |
Why?
|
Mesentery | 1 | 1997 | 205 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2001 | 1262 | 0.010 |
Why?
|
Nuclear Family | 1 | 1998 | 318 | 0.010 |
Why?
|
Half-Life | 1 | 1997 | 658 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1997 | 964 | 0.010 |
Why?
|
ROC Curve | 1 | 2003 | 3528 | 0.010 |
Why?
|
Cerebral Arteries | 1 | 1998 | 492 | 0.010 |
Why?
|
Mice | 4 | 2013 | 81045 | 0.010 |
Why?
|
Outpatients | 1 | 2003 | 1483 | 0.010 |
Why?
|
Blood | 1 | 1997 | 598 | 0.010 |
Why?
|
Observer Variation | 1 | 2001 | 2593 | 0.010 |
Why?
|
Prevalence | 1 | 2011 | 15194 | 0.010 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 1997 | 559 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1997 | 1866 | 0.010 |
Why?
|
Interleukin-4 | 1 | 1997 | 1146 | 0.010 |
Why?
|
Species Specificity | 1 | 1997 | 2479 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1997 | 1470 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 1997 | 1875 | 0.010 |
Why?
|
Salivary Gland Diseases | 1 | 1992 | 37 | 0.010 |
Why?
|
Family Health | 1 | 1998 | 1282 | 0.010 |
Why?
|
Submandibular Gland | 1 | 1992 | 86 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15108 | 0.010 |
Why?
|
Reference Values | 2 | 1989 | 4982 | 0.010 |
Why?
|
Conjunctival Diseases | 1 | 1993 | 121 | 0.010 |
Why?
|
Inpatients | 1 | 2003 | 2495 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 1997 | 1366 | 0.010 |
Why?
|
Fluoresceins | 1 | 1991 | 234 | 0.010 |
Why?
|
Cattle | 1 | 1997 | 3923 | 0.010 |
Why?
|
Protein Conformation | 1 | 1999 | 4013 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2001 | 3199 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1997 | 1780 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2000 | 2276 | 0.010 |
Why?
|
Critical Care | 1 | 2003 | 2640 | 0.010 |
Why?
|
Clathrin | 1 | 1991 | 265 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 1997 | 21821 | 0.010 |
Why?
|
Colon | 1 | 1997 | 1773 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 1997 | 1837 | 0.010 |
Why?
|
Dextrans | 1 | 1991 | 592 | 0.010 |
Why?
|
Interferon-gamma | 1 | 1997 | 3199 | 0.010 |
Why?
|
Models, Molecular | 1 | 1999 | 5454 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 1997 | 2133 | 0.010 |
Why?
|
Specimen Handling | 1 | 1993 | 692 | 0.010 |
Why?
|
Collagen | 1 | 1997 | 2684 | 0.000 |
Why?
|
Aging | 2 | 1997 | 8626 | 0.000 |
Why?
|
Rats, Inbred Strains | 1 | 1989 | 2191 | 0.000 |
Why?
|
Arthritis, Rheumatoid | 1 | 2003 | 3695 | 0.000 |
Why?
|
Histones | 1 | 1997 | 2597 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 2001 | 12242 | 0.000 |
Why?
|
Rabbits | 1 | 1993 | 4886 | 0.000 |
Why?
|
Adenosine Triphosphatases | 1 | 1991 | 836 | 0.000 |
Why?
|
Sex Factors | 1 | 2001 | 10392 | 0.000 |
Why?
|
Double-Blind Method | 1 | 2000 | 12017 | 0.000 |
Why?
|
Sex Characteristics | 1 | 1997 | 2585 | 0.000 |
Why?
|
Epithelium | 1 | 1991 | 1680 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1997 | 3465 | 0.000 |
Why?
|
Autopsy | 1 | 1990 | 1006 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1989 | 2645 | 0.000 |
Why?
|
Transfection | 1 | 1993 | 5892 | 0.000 |
Why?
|
Amino Acids | 1 | 1990 | 1727 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2001 | 19862 | 0.000 |
Why?
|
Chronic Disease | 1 | 1997 | 9144 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1993 | 8300 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 1998 | 5705 | 0.000 |
Why?
|
Cell Membrane | 1 | 1991 | 3744 | 0.000 |
Why?
|
Cell Line | 1 | 1993 | 15994 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1989 | 8621 | 0.000 |
Why?
|
DNA | 1 | 1989 | 7289 | 0.000 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1989 | 3336 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1989 | 15244 | 0.000 |
Why?
|